Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

NCT05633914 ·Status: RECRUITING ·Phase: PHASE2

Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

NCT01133912 ·Status: COMPLETED ·Phase: PHASE1

Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer

NCT00256243 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

NCT04126525 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Neoadjuvant Taxotere

NCT00206505 ·Status: COMPLETED ·Phase: PHASE2

MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer

NCT01263145 ·Status: COMPLETED ·Phase: PHASE1

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

NCT01625429 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

NCT00214864 ·Status: COMPLETED ·Phase: PHASE2

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

NCT01705340 ·Status: TERMINATED ·Phase: PHASE1

Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer

NCT04872985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients

NCT06825975 ·Status: NOT_YET_RECRUITING ·Phase: NA

Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer

NCT02903524 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane

NCT02658734 ·Status: COMPLETED ·Phase: PHASE4

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

NCT03423849 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer

NCT00154882 ·Status: UNKNOWN ·Phase: PHASE2

Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

NCT07179939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

NCT05728268 ·Status: RECRUITING ·Phase: PHASE2

Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer

NCT03054363 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

NCT01428414 ·Status: UNKNOWN ·Phase: PHASE2

Therapy Management With Nab-Paclitaxel in Daily Routine

NCT02642406 ·Status: UNKNOWN

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

NCT04182568 ·Status: UNKNOWN ·Phase: PHASE4

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

NCT02684032 ·Status: COMPLETED ·Phase: PHASE1

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

NCT03756064 ·Status: UNKNOWN ·Phase: NA

Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

NCT06819501 ·Status: NOT_YET_RECRUITING ·Phase: NA

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

NCT04278469 ·Status: RECRUITING ·Phase: NA